Piper Sandler raised the firm’s price target on Principal Financial (PFG) to $100 from $94 and keeps an Overweight rating on the shares. The firm is generally above consensus across the board in lifecoland. The drop in rates has been more gradual than has otherwise been expected, which has been constructive for broader capital markets activity too. This likely causes some tailwind to fee and spread earnings in its coverage, Piper adds. Claim 70% Off TipRanks This Holiday Season Published first on TheFly ...

I have a bullish thesis on Centerra Gold ( CGAU ) based upon both the high commodity price environment we are currently operating within and the structural transformation of the business model. We are seeing a company that has rebuilt its cashI am an investor specializing in the consumer products sector with a focus on identifying companies that offer a unique combination of strong brand recognition, solid financials, and growth potential. I have a keen eye for consumer trends and an in-depth understanding ...

Piper Sandler raised the firm’s price target on Prudential (PRU) to $120 from $110 and keeps a Neutral rating on the shares. The firm is generally above consensus across the board in lifecoland. The drop in rates has been more gradual than has otherwise been expected, which has been constructive for broader capital markets activity too. This likely causes some tailwind to fee and spread earnings in its coverage, Piper adds. Claim 70% Off TipRanks This Holiday Season Published first on TheFly – the ultima ...

Piper Sandler analyst John Barnidge raised the firm’s price target on Reinsurance Group (RGA) to $230 from $220 and keeps an Overweight rating on the shares. The firm is generally above consensus across the board in lifecoland. The drop in rates has been more gradual than has otherwise been expected, which has been constructive for broader capital markets activity too. This likely causes some tailwind to fee and spread earnings in its coverage, Piper adds. Claim 70% Off TipRanks This Holiday Season Publi ...

Canaccord raised the firm’s price target on Tesla (TSLA) to $551 from $482 and keeps a Buy rating on the shares. The firm reduced its Q4 delivery outlook for Tesla to 427,000 from 470,000, citing a sharper than anticipated deterioration in demand, with weakness broad-based across products and regions. However, even with the Q4 estimate cut, Canaccord sees “constructive developments beneath the surface” for Tesla. The recent share rally shows the market is looking through Q4, the analyst tells investors in ...

Group 1 - The core thesis on Centerra Gold (CGAU) is bullish, driven by a high commodity price environment and a structural transformation of the business model [1] - Centerra Gold has successfully rebuilt its cash position, indicating improved financial health and operational efficiency [1] Group 2 - The focus is on identifying companies in the consumer products sector that possess strong brand recognition, solid financials, and growth potential [1] - There is an emphasis on understanding consumer trends to identify profitable investment opportunities within the industry [1]

Shares of Dynavax Technologies jumped sharply in premarket trading on Wednesday after the US vaccine maker agreed to be acquired by French pharmaceutical group Sanofi in an all-cash deal valued at abo... ...

By Bhanvi Satija Dec 24 (Reuters) - Sanofi (SNY) will buy U.S. vaccines company Dynavax Technologies (DVAX) for around $2.2 billion (1.9 billion euros), the French drugmaker said on Wednesday, a deal that will give it access to an approved hepatitis ​B vaccine. Sanofi has made a string of acquisitions this year, as it looks to diversify growth beyond ‌its blockbuster asthma drug Dupixent. It bought UK private biotech firm Vicebio for $1.5 billion in July shortly after finalising an up to $9.5 billion dea ...

Sign in to access your portfolio Sign in ...

Sign in to access your portfolio Sign in ...